Please use this identifier to cite or link to this item:
Title: Patterns of glioblastoma treatment and survival over a 16-years period : pooled data from the German Cancer Registries
Author(s): Efremov, Ljupcho
Ferede Abera, Semaw
Bedir, Ahmed
Vordermark, Dirk
Medenwald, Daniel
Issue Date: 2021
Type: Article
Language: English
Abstract: Introduction: Glioblastoma multiforme (GBM) is a primary malignant brain tumour characterized by a very low long-term survival. The aim of this study was to analyse the distribution of treatment modalities and their effect on survival for GBM cases diagnosed in Germany between 1999 and 2014. Methods: Cases were pooled from the German Cancer Registries with International Classification of Diseases for Oncology, third edition (ICD-O-3) codes for GBM or giant-cell GBM. Three periods, first (January 1999–December 2005), second (January 2006–December 2010) and a third period (January 2011–December 2014) were defined. Kaplan–Meier plots with long-rank test compared median overall survival (OS) between groups. Survival differences were assessed with Cox proportional-hazards models adjusted for available confounders. Results: In total, 40,138 adult GBM cases were analysed, with a mean age at diagnosis 64.0 ± 12.4 years. GBM was more common in men (57.3%). The median OS was 10.0 (95% CI 9.0–10.0) months. There was an increase in 2-year survival, from 16.6% in the first to 19.3% in the third period. When stratified by age group, period and treatment modalities, there was an improved median OS after 2005 due to treatment advancements. Younger age, female sex, surgical resection, use of radiotherapy and chemotherapy, were independent factors associated with better survival. Conclusion: The inclusion of temozolomide chemotherapy has considerably improved median OS in the older age groups but had a lesser effect in the younger age group of cases. The analysis showed survival improvements for each treatment option over time.
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Sponsor/Funder: Publikationsfonds MLU
Journal Title: Journal of Cancer Research and Clinical Oncology
Publisher: Springer
Publisher Place: Berlin
Volume: 147
Original Publication: 10.1007/s00432-021-03596-5
Page Start: 3381
Page End: 3390
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
Efremov2021_Article_PatternsOfGlioblastomaTreatmen.pdf474.28 kBAdobe PDFThumbnail